JJIF

Athletes’ responsibilities include (but are not limited to): 

  • complying with the JJIF’s Anti-Doping Rules, policies and practices;
  • Being available for testing at all times; 
  • Ensuring that no prohibited substance enters their body and that no prohibited method is used; 
  • Informing medical personnel of their obligation not to use any substances or methods prohibited according to the Prohibited List in force and taking responsibility to make sure that any medical treatment received does not violate anti-doping rules;
    • Applying for a Therapeutic Use Exemption (TUE)  to the JJIF (or the national anti-doping organisation if the athlete is a national level athlete) if no alternative permitted treatment is possible (see the JJIF’s TUE application process); 
    • Cooperating with anti-doping organisations investigating anti-doping rules violations (ADRVs); and 
    • Disclosing to JJIF and to their National Anti-Doping Organisation any decision finding that the Athlete committed an anti-doping violation within the previous ten years.

Click here to learn about Athlete’s rights.

ATHLETES’ COMMITMENT

In accordance with the WADA rules and the JJIF regulations, the Athletes’ Commission has elaborated an Athlete’s Commitment document, which includes the athlete’s anti-doping commitment.

Click HERE to download the Athlete’s Commitment which includes their Anti-Doping Commitment.

An Athlete’s Guide to the Significant Changes in the 2021 Code is also available on WADA’s Anti-Doping Education and Learning Platform (ADEL).

Its purpose is to help you understand the main changes to the World Anti-Doping Code (Code), especially those that have the greatest impact on you. Protecting your health and your anti-doping rights are at the center of our and WADA’s efforts in protecting clean sport. While nothing replaces the actual words of the Code or your Anti-Doping Organisation’s (ADO) anti-doping rules (the legally binding documents), this Guide aims to give you a simplified overview of what has changed in 2021.